AU Patent

AU2018378348B2 — Crystal forms and production methods thereof

Assigned to Sumitomo Pharma America Inc · Expires 2024-09-19 · 2y expired

What this patent protects

The various aspects present inventions provide various crystalline forms of (S)-(-)-amisulpride, (R)-(+)-amisulpride, and solvates thereof and methods of making same. In various aspects, the inventions also provide methods of resolving racemic amisulpride.

USPTO Abstract

The various aspects present inventions provide various crystalline forms of (S)-(-)-amisulpride, (R)-(+)-amisulpride, and solvates thereof and methods of making same. In various aspects, the inventions also provide methods of resolving racemic amisulpride.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018378348B2
Jurisdiction
AU
Classification
—
Expires
2024-09-19
Drug substance claim
No
Drug product claim
No
Assignee
Sumitomo Pharma America Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.